morantel (Compound)

Synonyms:morantel, 20574-50-9, Pyrimidine, 1,4,5,6-tetrahydro-1-methyl-2-(2-(3-methyl-2-thienyl)ethenyl)-, (E)-, 7NJ031HAX5, 20574-50-9 (free base), (E)-1-methyl-2-(2-(3-methylthiophen-2-yl)vinyl)-1,4,5,6-tetrahydropyrimidine, Pyrimidine, 1,4,5,6-tetrahydro-1-methyl-2-[(1E)-2-(3-methyl-2-thienyl)ethenyl]-, Morantelum, Morantel [INN:BAN], (E)-Morantel, Morantelum [INN-Latin], Pyrimidine, 1,4,5,6-tetrahydro-1-methyl-2-[2-(3-methyl-2-thienyl)ethenyl]-, (E)-, EINECS 243-890-8, UNII-7NJ031HAX5, UK 2964-18, Morantel (BAN), MORANTEL [INN], MORANTEL [MI], Spectrum5_001573, Banminth II (Salt/Mix), MORANTEL [MART.], (E)-1,4,5,6-Tetrahydro-1-methyl-2-(2-(3-methyl-2-thienyl)vinyl)pyrimidin, trans-1,4,5,6-Tetrahydro-1-methyl-2-(2-(3-methyl-2-thienyl)vinyl)pyrimidine, BSPBio_002611, SCHEMBL123923, CHEMBL1240978, DTXSID9048562, BDBM62879, CHEBI:94736, cid_6419965, Paratect flex [veterinary] (TN), 1-methyl-2-[(E)-2-(3-methylthiophen-2-yl)ethenyl]-5,6-dihydro-4H-pyrimidine, IDI1_000866, NCGC00178575-01, NCGC00178575-02, SBI-0051865.P002, D08230, AB00053685_12, BRD-K74820615-045-01-9, Q27268618, 1-Methyl-2-[2-(3-methyl-2-thienyl)vinyl]-1,4,5,6-tetrahydropyrimidine, trans-1,4,5,6-Tetrahydro-1-methyl-2-[(3-methyl-2-thienyl)vinyl]pyrimidine, (E)-1,4,5,6-Tetrahydro-1-methyl-2-(2-(3-methyl-2-thienyl)ethenyl)pyrimidine, (E)-1,4,5,6-TETRAHYDRO-1-METHYL-2-(2-(3-METHYL-2-THIENYL)VINYL)PYRIMIDINE, 1-Methyl-2-[(E)-2-(3-methyl-2-thienyl)ethenyl]-1,4,5,6-tetrahydropyrimidine, 1-methyl-2-[(E)-2-(3-methyl-2-thienyl)vinyl]-5,6-dihydro-4H-pyrimidine;tartaric acid, Pyrimidine, 1,4,5,6-tetrahydro-1-methyl-2-[(E)-2-(3-methyl-2-thienyl)ethenyl]-, 2,3-bis(oxidanyl)butanedioic acid;1-methyl-2-[(E)-2-(3-methylthiophen-2-yl)ethenyl]-5,6-dihydro-4H-pyrimidine, 2,3-dihydroxybutanedioic acid;1-methyl-2-[(E)-2-(3-methyl-2-thiophenyl)ethenyl]-5,6-dihydro-4H-pyrimidine

Pubchem:PUBCHEM:4250

Id:682689f8-9ab3-5a44-8b53-1eb930501db3

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View morantel's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for morantel.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with morantel.

Results found

Linked to

	Label	Description
	BRD-K74820615-045-01-9 Substance (Entity type)	A Substance
	DCSTRUCT ID 05582 Collection (Entity type)	DrugPage Collection: (DrugCentralID:05582; PubChem_CID:5353792, FILE=drugcentral_drug_05582.json)
	morantel negatively regulates CXCL14 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	morantel negatively regulates SLPI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	morantel positively regulates PTPRN2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	morantel in similarity relationship with cytosporone B Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	morantel positively regulates TM4SF1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	morantel negatively regulates KRT14 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	morantel negatively regulates WFDC1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	morantel negatively regulates HEATR1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS